期刊文献+

基于煨脓长肉理论探讨紫朱软膏通过NLRP3逆转糖尿病难愈性创面巨噬细胞胞葬逃逸的机制研究

Exploring the Mechanism of Hematite Ointment to Reverse the Macrophage Efferocytosis Escape of Diabetic Refractory Wound through NLRP3 Based on the Theory of Weinong Zhangrou
下载PDF
导出
摘要 目的:初步探讨紫朱软膏过NLRP3逆转糖尿病难愈性创面巨噬细胞胞葬逃逸的相关机制。方法:48只C57BL/6小鼠随机分为普通创面模型组、糖尿病创面模型组、紫朱软膏干预组、NLRP3抑制剂组,每组12只。提取创面组织巨噬细胞与凋亡Jurkat细胞共培养,创面拍照并记录创面愈合率,应用RT-qPCR、Western blot、流式细胞仪检测巨噬细胞胞葬能力、NLRP3通路及胞葬相关因子mRNA和蛋白的表达水平。结果:普通创面模型组、紫朱软膏干预组、NLRP3抑制剂组的创面愈合率明显高于糖尿病创面模型组(P<0.01);与普通创面组对比,糖尿病创面模型组巨噬细胞胞葬功能降低明显(P<0.01),NLRP3、Caspase-1 mRNA及蛋白表达水平显著上调(P<0.01),AXL、TYRO3、MFGE8表达水平显著降低(P<0.01);与糖尿病创面模型组相比,紫朱软膏干预组胞葬功能显著提升(P<0.01),NLRP3、Caspase-1 mRNA及蛋白水平显著降低(P<0.01),AXL、TYRO3、MFGE8表达水平显著上调(P<0.05,P<0.01);与糖尿病创面模型组相比,NLRP3抑制剂组巨噬细胞胞葬功能显著提升(P<0.01),NLRP3、Caspase-1 mRNA及蛋白表达水平显著降低(P<0.01),AXL、TYRO3、MFGE8表达水平显著上调(P<0.05,P<0.01)。结论:紫朱软膏可能通过NLRP3通路逆转巨噬细胞胞葬逃逸,从而促进糖尿病创面愈合。 Objective:To investigate the mechanism of hematite ointment reversing macrophage efferocytosis escape in refractory wound of diabetes through NLRP3.Methods:48 C57BL/6 mice were randomly divided into common ulcer model group,diabetes wound model group,hematite ointment intervention group,and NLRP3 inhibitor group.Macrophages were extracted from the wound tissue and co-cultured with apoptotic Jurkat cells.The wound was photographed and the wound healing rate recorded.RT-qPCR,Western blot and flow cytometry were used to detect the efferocytosis capacity of macrophages,NLRP3 pathway and the expression level of mRNA and proteins related to efferocytosis factors.Results:The wound healing rate of the common ulcer model group,hematite ointment intervention group,and NLRP3 inhibitor group was significantly higher than that of the diabetes wound model group(P<0.05).Compared with the common ulcer model group,the efferocytosis function of macrophages in the diabetes wound model group was significantly reduced,the expression levels of NLRP3,Caspase-1 mRNA and protein were significantly upregulated,and the expression levels of AXL,TYRO3,MFGE8 were significantly decreased(P<0.05).Compared with the diabetes wound model group,the hematite ointment intervention group significantly improved the efferocytosis function,significantly reduced the levels of NLRP3,Caspase-1 mRNA and proteins,and significantly upregulated the expression levels of AXL,TYRO3,and MFGE8(P<0.05);Compared with the diabetes wound model group,the efferocytosis function of macrophages in the NLRP3 inhibitor group was significantly increased,the expression levels of NLRP3,Caspase-1 mRNA and proteins were significantly decreased,and the expression levels of AXL,TYRO3,and MFGE8 were significantly upregulated(P<0.05).Conclusion:Hematite ointment,a traditional Chinese medicine for Weinong Zhangrou,may reverse the efferocytosis escape of macrophages through NLRP3 pathway,thus promoting the healing of diabetes wounds.
作者 樊炜静 李文惠 卢慧敏 柳国斌 FAN Weijing;LI Wenhui;LU Huimin;LIU Guobin(Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Shanghai University of Medicine&Health Sciences,Shanghai 201318,China)
出处 《中医药学报》 CAS 2023年第11期29-35,共7页 Acta Chinese Medicine and Pharmacology
基金 国家自然科学基金面上项目(82274528) 上海市进一步加快中医药传承创新发展三年行动计划[ZY(2021-2023)-0211] 上海市卫生健康委员会卫生行业临床研究专项青年项目(20234Y0162) 上海中医药大学附属医院临床研究型骨干人才培养计划(2023LCRC06) 上海中医药大学附属曙光医院四明基金(SGKJ-202301)。
关键词 煨脓长肉 紫朱软膏 NLRP3 胞葬 糖尿病溃疡 Weinong Zhangrou Hematite ointment NLRP3 Efferocytosis Diabetes ulcer
  • 相关文献

参考文献6

二级参考文献268

  • 1无,杨博华,鞠上.中西医结合防治糖尿病足中国专家共识(第1版)[J].血管与腔内血管外科杂志,2019,5(5):379-402. 被引量:83
  • 2杜玉青,刘亚莉,李友山,刘凤桐,黄天一,庞鹤.基于《外科正宗·脱疽》探讨不同分期糖尿病足外治法的辨证用药特点[J].世界科学技术-中医药现代化,2020,22(8):2969-2974. 被引量:19
  • 3阙华发,唐汉钧,陆德铭.外科煨脓长肉湿润法研究[J].中华中医药学刊,1999,23(2):3-5. 被引量:51
  • 4Shahbazian H, Yazdanpanah L, Latifi SM. Risk assessmentof patients with diabetes for foot ulcers according to riskclassification consensus of International Working Group onDiabetic Foot (IWGDF). Pak J Med Sci 2013; 29: 730-734 [PMID:24353617 DOI: 10.12669/pjms.293.3473].
  • 5Ramachandran A, Snehalatha C, Shetty AS, Nanditha A.Trends in prevalence of diabetes in Asian countries. World JDiabetes 2012; 3: 110-117 [PMID: 22737281 DOI: 10.4239/wjd.v3.i6.110].
  • 6Shaw JE, Sicree RA, Zimmet PZ. Global estimates of theprevalence of diabetes for 2010 and 2030. Diabetes ResClin Pract 2010; 87: 4-14 [PMID: 19896746 DOI: 10.1016/j.diabres.2009.10.007].
  • 7Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetesatlas: global estimates of the prevalence of diabetes for 2011and 2030. Diabetes Res Clin Pract 2011; 94: 311-321 [PMID:22079683 DOI: 10.1016/j.diabres.2011.10.029].
  • 8Aalaa M, Malazy OT, Sanjari M, Peimani M, Mohajeri-Tehrani M. Nurses’ role in diabetic foot prevention andcare; a review. J Diabetes Metab Disord 2012; 11: 24 [PMID:23497582 DOI: 10.1186/2251-6581-11-24].
  • 9Alavi A, Sibbald RG, Mayer D, Goodman L, Botros M,Armstrong DG, Woo K, Boeni T, Ayello EA, Kirsner RS.Diabetic foot ulcers: Part II. Management. J Am Acad Dermatol2014; 70: 21.e1-2124; quiz 21.e1-2124 [PMID: 24355276 DOI:10.1016/j.jaad.2013.07.048].
  • 10Cavanagh PR, Lipsky BA, Bradbury AW, Botek G.Treatment for diabetic foot ulcers. Lancet 2005; 366: 1725-1735[PMID: 16291067 DOI: 10.1016/S0140-6736(05)67699-4].

共引文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部